Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for CD3 and uses thereof

Antibodies specific for CD3 and uses thereof

US Patent 11434292 · Granted Sep 6, 2022

Estimated economic value: $2,117,413,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Antibody molecules that bind to NKP30 and uses thereof2025
CDCP1 antibodies and antibody drug conjugates2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Antibodies specific for GUCY2c and uses thereof2025
Antibodies specific for GUCY2c and uses thereof2025
Anti-GDF15 antibodies, compositions and methods of use2025
Tissue factor pathway inhibitor antibodies and uses thereof2024
Therapeutic antibodies and their uses2023
Single domain binding molecule2023
Tissue factor pathway inhibitor antibodies and uses thereof2023
Antibodies and antibody-drug conjugates specific for CD123 and uses thereof2023